scispace - formally typeset
U

Ulla G. Sidelmann

Researcher at Novo Nordisk

Publications -  26
Citations -  1843

Ulla G. Sidelmann is an academic researcher from Novo Nordisk. The author has contributed to research in topics: Glucuronide & Metabolite. The author has an hindex of 22, co-authored 26 publications receiving 1791 citations. Previous affiliations of Ulla G. Sidelmann include Birkbeck, University of London.

Papers
More filters
Journal ArticleDOI

CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.

TL;DR: An important role for both CYP3A4 and CYP2C8 in the human in vitro biotransformation of repaglinide is confirmed, which may have consequences for the clinical pharmacokinetics and drug-drug interactions involving repaglinside if one CYP pathway has sufficient capacity to compensate if the other is inhibited.
Journal ArticleDOI

Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models

TL;DR: Mapping metabotypic QTLs provides a practical approach to understanding genome-phenotype relationships in mammals and may uncover deeper biological complexity, as extended genome perturbations that affect disease processes through transgenomic effects may influence QTL detection.
Journal ArticleDOI

Directly Coupled HPLC-NMR and Its Application to Drug Metabolism

TL;DR: Directly coupled HPLC-NMR and its application to drug metabolism was discussed in this paper, where the authors present a comparison of the two types of NMR-based methods.